Published 10 days ago • loading... • Updated 8 days ago

Piper Sandler Raises Gilead Sciences (NASDAQ:GILD) Price Target to $110.00

Summary by themarketsdaily.com

Gilead Sciences (NASDAQ:GILD – Get Free Report) had its price target raised by research analysts at Piper Sandler from $105.00 to $110.00 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage currently has an “overweight” rating on the biopharmaceutical company’s stock. Piper Sandler’s target price indicates a potential upside of 3.81% from […]

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

All

Left

Center

Right

themarketsdaily.com

Piper Sandler Raises Gilead Sciences (NASDAQ:GILD) Price Target to $110.00

8 days ago

Read Full Article

watchlistnews.com

Gilead Sciences, Inc. (NASDAQ:GILD) Increases Dividend to $0.79 Per Share

Gilead Sciences, Inc. (NASDAQ:GILD – Get Free Report) declared a quarterly dividend on Wednesday, February 12th,Wall Street Journal reports. Stockholders of record on Friday, March 14th will be given a dividend of 0.79 per share by the biopharmaceutical company on Friday, March 28th. This represents a $3.16 annualized dividend and a dividend yield of 3.06%. […]

10 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right